Study Questions Whether Side Effects of Xeljanz, Similar Drugs, Increase Blood Clot Risks
A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.
A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.
A request for approval for Olumiant to treat lupus has been withdrawn, and the manufacturers expect the FDA to reject an atopic dermatitis approval request in the face of growing…